Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies

Condition:   Dementia With Lewy Bodies Interventions:   Drug: Placebo oral capsule;   Drug: Nilotinib Oral Capsule Sponsors:   Georgetown University;   National Institutes of Health (NIH) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials